cas 1159820-98-0|| where to buy 6-(piperazin-1-yl)pyrimidin-4-amine

Produktname:6-(piperazin-1-yl)pyrimidin-4-amine

IUPAC Name:6-(piperazin-1-yl)pyrimidin-4-amine

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM130794-1g	in stock	ŗƥŗ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1159820-98-0 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1159820-98-0; Molekulare Formel:C8H13N5; Schmelzpunkt:-; SMILES-Code:NC1=CC(=NC=N1)N1CCNCC1; Dichte:

: Katalognummer:CM130794; Molekulargewicht:179.23; Siedepunkt:; Mdl-Nr.:MFCD12033531; Lagerung:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.